73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Can what works to treat cancer work for diabetes?

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only
Head injuries could be a risk factor for developing brain cancer

Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop
Clinical trial shows efficacy for atezolizumab combined with carboplatin

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati
Existing drug shows promise treating most prevalent type of lung cancer

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t
Early menopause appears raise odds of breast cancer, study reports

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear

Early menopause appears raise odds of breast cancer, study reports

by Dennis Thompson.Women who underwent menopause at an age younger than 46 were nearly twice as likely to havebreast cancercompared to others their age, researchers found.The study, appear
Scientists discover how the body's killer cells attack cancer

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working
Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n
Aging and cancer hallmarks as therapeutic targets

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and
Key insights from statistical modeling of cancer patient life expectancy

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t
Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia
Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of
How do we know health screening programs work?

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d